Three different Pax6 promoters -P0, P1, and Pa -show differential activity in the developing eye and spinal cord. To examine promoter usage during forebrain development, we performed in situ hybridization and reverse transcription-polymerase chain reaction to detect transcripts initiated from each promoter. Promoter-specific transcripts are expressed within subdomains of total Pax6 expression, but differ from one another in their spatial localization and expression over time. Additionally, we identified a novel P0-initiated transcript and detected a developmentally regulated antisense transcript. q
Results and discussion

Alternate 5
0 promoters, P0 and P1, and a putative internal promoter near the a enhancer/exon, here termed Pa, have been reported for the mouse Pax6 gene (Kammandel et al., 1999; Xu et al., 1999) . P0 and P1 promoters show differential activity in the developing retina, while isolated promoter elements restrict gene expression to domains of the forebrain, eye, and spinal cord (Xu and Saunders, 1998; Xu et al., 1999; Kammandel et al., 1999; Ashery-Padan et al., 2000; Marquardt et al., 2001) . To determine the spatial and temporal activity of intact promoters within the developing mouse forebrain, we charted the expression of promoter-specific transcripts using in situ hybridization. Riboprobes containing sequences complementary to exons 0, 1, and a were used to visualize P0, P1, and Paspecific transcripts, respectively. For comparison, total Pax6 mRNA was visualized with a probe complementary to paired and homeodomain sequences. P1-initiated transcripts were expressed first and were detected as early as embryonic day 8 (E8.0) in the hindbrain and caudal neural tube (Fig. 1) ; by E9.5, transcripts were also expressed in the forebrain. By E10.5, P1-, P0-, and Pa-initiated transcripts were present in the forebrain, but only P1-initiated transcripts were expressed caudally. At this age, P1-initiated transcript levels were higher than those of either P0-or Pa-initiated transcripts. P1-initiated transcripts continued to predominate at later stages (Table 1, Fig. 2 and data not shown), however Pa-and to a lesser degree, P0-initiated transcripts showed transient increases at E15.5. At this stage, all three transcripts were expressed in discrete telencephalic and diencephalic domains (Fig. 2) . Transcripts were present in neocortex, hippocampus, ventral pallidum, epithalamus, and ventral thalamic nuclei. P1-and Pa-initiated transcripts were present throughout the hippocampal proliferative zone, whereas P0-initiated transcripts appeared restricted to Ammon's horn. In the diencephalon, P0-initiated transcript levels were low in the LGN, PN, and along the EML compared to P1-and Pa-initiated transcript levels.
Control experiments using an exon a sense probe (complementary to the Pa probe) revealed the presence of an antisense Pax6 species (Fig. 1) . This transcript was present in the rostral neural plate and at low levels in the fused neural tube at E8.0. Expression in the forebrain increased to high levels at E9.5. Although still apparent in the hindbrain, forebrain expression had waned by E10.5.
To independently verify the presence of three distinct sets of P0, P1, or Pa-initiated transcripts we performed (02)00051-5 www.elsevier.com/locate/modo reverse transcription-polymerase chain reaction (RT-PCR) using primers for promoter-specific exons and exon 5, the first common exon (Walther and Gruss, 1991; Kammandel et al., 1999; Xu et al., 1999; Fig. 3) . Transcripts amplified by this approach should differ at their 5 0 ends but share downstream sequence. P1 transcript amplification yielded two bands of ,550 and ,650 bp, for which sequencing demonstrated the variable inclusion of exon 1 0 (Xu et al., 1999) . Pa transcript amplification produced a ,450 bp band, consistent with the reported splicing pattern (Kammandel et al., 1999) . Amplification of P0-initated mRNAs produced a band of 310 bp. The sequence downstream of exon 0 in this forebrain cDNA corresponded to bp 31-211 of a 2.4 kb Pax6 cDNA (Walther and Gruss, 1991) . Based on alignment with human Pax6, this segment appeared to contain exons 4 and 5 and an upstream sequence (bp 31-108) that had no human equivalent but is presumably exon 3 (Fig. 3D ). This forebrain splice variant differed from a P0-initiated lens transcript containing exon 2 (Xu et al., 1999) . RT-PCR using an exon 2 primer demonstrated that this lens transcript was also present in forebrain (Fig. 3C ). This analysis of Pax6 mRNA expression in the developing forebrain indicates differential promoter usage, novel alternative splicing, and antisense transcript expression. The activity of intact Pax6 promoters is not recapitulated by isolated cis elements (Xu and Saunders, 1998; Xu et al., 1999; Kammandel et al., 1999) . However, the temporal pattern of P0 and P1 activation parallels that seen in the developing quail retina, where coordination of promoter Kammandel et al., 1999; Xu et al., 1999) . Digoxigenin-labeled riboprobes were used to detect promoter-specific exons 0 (red), 1 (yellow), and a (blue), and paired/homeodomain-encoding exon 7 (purple). The probes are complementary to the following sequences: P0 (bp 578-895, accession no. AF008212), P1 (bp 3901-4305, accession no. AF098640), Pa (bp 127-543, accession no. 008213), and Prd (bp 579-1424, accession no. NM_013627). Lower panels depict expression of transcripts initiated from P0 (C,H,M), P1 (D,I,N), and Pa (E,J,O), as well as the exon a antisense transcript (aAS; F,K,P), and total Pax6 expression (Prd; B,G,L) in whole embryos at E8.0 (B-F), E9.5 (G-K), and E10.5 (L-P). Rostral is to the left in all panels. Total Pax6 expression (B) and P1 transcript expression (D) at E8.0 extend from the rostral margin of the hindbrain (arrows) to the level of the open neural plate. By E9.5, P1 transcript expression is apparent in broad domains of the developing forebrain (FB) and in both the hindbrain and spinal cord (SC) but not the midbrain (I). At E10.5, P1 transcripts are still apparent in SC and in FB, with a sharp border of expression (arrowhead) at the forebrain-midbrain boundary (N). P0 and Pa transcripts are also weakly expressed in FB at this age (M,O; arrowheads). Antisense transcripts are visible in FB and SC at E9.5 (K). By E10.5, forebrain antisense expression is faint (O). In contrast, antisense expression is strong along the rhombic lip (P, inset). The expression domains of all promoter-specific transcripts are subsets of total Pax6 expression (Prd; B, G, L). 
a Levels of expression indicated represent qualitative evaluation of riboprobe signal intensity. Intensity was considered relative to the strongest signal seen for any probe (P0, P1, or Pa) across ages. These levels also reflect expression of a given transcript within a given forebrain region relative to other regions. Intensity scale: -, not detected; 1/-, minimally detected; 1, low; 11 or 111, moderate; 1111, high.
b Basal telencephalon refers to the amygdala at E12.5 and to the ventral pallidum at E15.5 and E17.5. c Anatomical abbreviations: VT, ventral thalamus; IZ, intermediate zone. Fig. 2 . Analysis of Pax6 transcript expression in E15.5 forebrain using in situ hybridization. In the rostral telencephalon high levels of P1 transcript expression (C) and lower levels of Pa transcript expression (D) are detected in the hippocampus, H; neocortex, NC; and ventral pallidum, VP. P0 transcript expression is very low in the neocortex and ventral pallidum but slightly higher in hippocampus (B). Caudally (E-H, higher magnification in I-P), all transcripts are apparent in the intermediate zone of epithalamus, E, and in the external medullary lamina, EML. High P1 transcript expression (K), and moderate Pa transcript expression (L) is apparent in both the subiculum, S, and Ammon's horn, AH. In contrast to the faint neocortical expression seen rostrally, P0 transcripts are only visible in AH at this more caudal level (J). Ventrally in the diencephalon all promoter-specific transcripts (N-P) are apparent in the lateral geniculate nucleus, LGN, and the paraventricular nucleus, PN, although P0 transcript levels are substantially lower in these regions. The expression domains of all promoter-specific transcripts are subsets of total Pax6 expression (A,E,I,M).
usage with neural differentiation has been proposed (Plaza et al., 1995) .
Materials and methods
DNA templates for probes were synthesized from mouse genomic DNA using PCR, cloned into pBluescript (Stratagene), and sequenced. Riboprobes transcribed from templates using dUTP-digoxigenin (Roche) were hybridized to whole and sectioned C57Bl/6 embryos (Henrique et al., 1995) . For RT-PCR, total RNA (RNAwiz, Ambion) was isolated from E12.5 forebrain (minus eyes) and DNase treated. cDNAs synthesized using SuperscriptII (Life Technologies) were amplified with promoter-specific primers. PCR products were column purified (Qiaquick, Qiagen) either directly or after gel electrophoresis and sequenced. (Kammandel et al., 1999; Xu et al., 1999) . Relative positions of exons were determined by comparison with human genomic sequence (CFAT5 cosmid, accession no. Z95332). Presumed exon 3 (dotted outline) has no equivalent human sequence. Orientation of primers used for RT-PCR is shown (arrows). Promoter-specific exons 0, 1, and a are shaded gray. Colored exons are differentially incorporated into P0-initiated transcripts as described below. Comparison of the P0-e5 and P0-e2 sequences. P0-e5 contains exon 0 (boxed) followed by presumed exons 3 (black, preceded by arrowhead) and 4 (green), and exon 5 (blue) sequences. P0-e2 contains exon 0 (boxed) and exon 2 (purple). Reverse primer sequences are underlined.
